Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
3,071,963
-
Shares change
-
+724,514
-
Total reported value, excl. options
-
$176,501,646
-
Value change
-
+$41,474,999
-
Put/Call ratio
-
108%
-
Number of buys
-
21
-
Number of sells
-
-21
-
Price
-
$57.45
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q3 2016
63 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q3 2016.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,071,963 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (1,800,108 shares), CITIGROUP INC (650,610 shares), RAYMOND JAMES & ASSOCIATES (92,546 shares), MORGAN STANLEY (68,377 shares), Lumina Fund Management LLC (64,400 shares), CITADEL ADVISORS LLC (45,846 shares), Virtu Financial LLC (40,385 shares), BANK OF AMERICA CORP /DE/ (31,352 shares), ASPIRIANT, LLC (29,495 shares), and STUYVESANT CAPITAL MANAGEMENT (27,360 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.